Latest Headlines
-
SPL Now Offers Dioxin Testing Services To Support Environmental And Public Health Initiatives
4/8/2025
SPL Environmental, a leader in analytical laboratory testing, is proud to announce the addition of targeted dioxin testing for 2,3,7,8-Tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) to its suite of advanced, specialty laboratory services.
-
Graves Gilbert Clinic And Labcorp Finalize Strategic Agreement For Lab Operations
4/3/2025
Labcorp a global leader in innovative and comprehensive laboratory services, and Graves Gilbert Clinic have finalized a strategic collaboration in which Labcorp will manage the laboratory operations of Graves Gilbert Clinic’s full-service laboratories in Bowling Green and Glasgow, Kentucky.
-
LabTAG And eLabNext Launch New Add-On For DYMO LabelWriter 5-Series For Seamless Laboratory Labeling
4/3/2025
GA International, a global leader in laboratory identification solutions, under its LabTAG brand, announced today that its Dymo LabelWriter 5-Series Printing Kits are now compatible with eLabNext’s Digital Lab Platform (DLP), an intuitive and flexible system for collecting, managing, and analyzing laboratory information.
- Novel Point-Of-Care Technology Delivers Accurate HIV Results In Minutes 4/2/2025
-
Revvity Secures FDA Approval For Improved Automated Latent Tuberculosis Test
4/2/2025
Revvity, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the Auto-Pure 2400 liquid handling platform with the T-SPOT.TB test.
-
SEKISUI Diagnostics To Provide Metrix® COVID/Flu Test To The Point-Of-Care And Home Test Markets
4/2/2025
SEKISUI Diagnostics, a global medical diagnostics manufacturer, announces the launch of the Metrix® COVID/Flu Test, the second assay on the Metrix® Molecular Platform for use at the point-of-care and in the home.
-
Labcorp Launches First-Of-Its-Kind Immunoassay To Accelerate Path To Diagnosis Of Alzheimer's Disease
4/2/2025
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide launch of its pTau-217/Beta Amyloid 42 Ratio, a powerful new blood-based biomarker test to aid in the diagnosis of Alzheimer's disease.
-
Thermo Fisher Scientific Launches The Krios 5 Cryo-Transmission Electron Microscope (TEM), Boosting Productivity And Performance With Enhanced Automation
4/2/2025
Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific Krios 5 Cryo-TEM.
-
Waters Expands Alliance iS Bio HPLC Product Line With Photodiode Array Detector To Enhance Spectral Insights For Biopharma Development & QC
4/1/2025
Waters Corporation (NYSE:WAT) today announced the expansion of the Alliance™ iS Bio HPLC product line with integrated photodiode array (PDA) detection, advancing the capabilities of the next-generation intelligent HPLC platform designed for development and Quality Control (QC) laboratories.
-
MEPSGEN Announces U.S. Launch Of NanoCalibur™ For Lab-Scale To Preclinical Nanoparticle Production
4/1/2025
MEPSGEN US Inc., a global innovator in scalable nanoparticle production technology, announced today the launch of NanoCalibur™, a cutting-edge, scalable nanoparticle (NP) production system in the United States (US).